Watch onFRANKFURT - Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the drug's extended indication wins European approval.
German health agency G-BA said in guidance documents last week that regulation banning Germany's health system from paying for weight-loss drugs such as Wegovy would not apply in the case of other approved uses of the weekly injection, a boost for Novo Nordisk's efforts to convince governments of its wider medical benefits.
"We are looking forward to demonstrating the value of Wegovy in an official HTA process," Novo said on Monday in response to a question from Reuters about whether it would seek German coverage. Novo added that Wegovy would first need EU approval for use in cardiovascular risk reduction and the drug would have to"officially fall into the area of reimbursable conditions", in Germany.
Source: Insurance Report (insurancereport.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo ready to seek German insurance coverage of Wegovy for heart useExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »
Eli Lilly and Novo Nordisk's Diabetes Drugs Being Studied for Other Health BenefitsEli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are being investigated for potential health benefits beyond diabetes treatment. A study is examining whether Novo's Wegovy can reduce alcohol intake in patients with early Alzheimer's disease. Another study is testing Novo's semaglutide in combination with clot removal therapy for stroke patients. Lilly is also conducting research on the effects of their drugs on Alzheimer's disease and obesity.
Source: CTVNews - 🏆 1. / 99 Read more »
Germany's health insurance could cover Wegovy for strokes, heart conditions, agency saysExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »
Wegovy gains Medicare, Medicaid coverage for heart benefitsNovo Nordisk's (NVO) weight-loss medication, Wegovy, will now be covered by Medicare and Medicaid. This decision comes in light of the drug's demonstrated...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Medicare can pay for obesity drugs like Wegovy in certain heart patientsMedicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Wegovy to be covered by US Medicare for heart disease patientsExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »